[1] [1] I. P. Chatziralli, "The role of dyslipidemia control in the progression of diabetic retinopathy in patients with type 2 diabetes mellitus," Diab. Ther. 8(2), 209–212 (2017), doi: 10.1007/s13300-017-0240-0.

[2] [2] D. Huang, E. A. Swanson, C. P. Lin et al., "Optical coherence tomography," Science 254(5035), 1178–1181 (1991), doi: 10.1126/science.1957169.

[3] [3] S. Saxena, M. Caprnda, S. Ruia et al., "Spectral domain optical coherence tomography based imaging biomarkers for diabetic retinopathy," Endocrine 66(3), 509–516 (2019), doi: 10.1007/s12020-019-02093-7.

[4] [4] A. ElTanboly, M. Ismail, A. Shalaby et al., "A computer-aided diagnostic system for detecting diabetic retinopathy in optical coherence tomography images," Med. Phys. 44(3), 914–923 (2017), doi: 10.1002/mp.12071.

[5] [5] R. F. Spaide, J. G. Fujimoto, N. K. Waheed, S. R. Sadda, G. Staurenghi, "Optical coherence tomography angiography," Prog. Retin Eye Res. 64, 1–55 (2018), doi: 10.1016/j.preteyeres.2017.11.003.

[6] [6] M. Ang, A. C. S. Tan, C. M. G. Cheung et al., "Optical coherence tomography angiography: A review of current and future clinical applications," Graefes Arch. Clin. Exp. Ophthalmol. 256(2), 237–245 (2018), doi: 10.1007/s00417-017-3896-2.

[7] [7] F. Pichi, D. Sarraf, S. Arepalli et al., "The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases," Prog. Retin Eye Res. 59, 178–201 (2017), doi: 10.1016/j.preteyeres.2017.04.005.

[8] [8] J. M. Garcia, T. T. Lima, R. N. Louzada, A. T. Rassi, D. L. Isaac, M. Avila, "Diabetic macular ischemia diagnosis: Comparison between optical coherence tomography angiography and fluorescein angiography," J. Ophthalmol. 2016, 3989310 (2016), doi: 10.1155/2016/3989310. Epub 2016 Nov

[9] [9] PMID: 27891250; PMCID: PMC5116522.

[10] [10] L. Yeung, W. C. Wu, L. H. Chuang, N. K. Wang, C. C. Lai, "Novel optical coherence tomography angiography biomarker in branch retinal vein occlusion macular edema," Retina 39(10), 1906–1916 (2019), doi: 10.1097/IAE.0000000000002264.

[11] [11] F. Coscas, D. Cabral, T. Pereira et al., "Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission," PLoS One 13(10), e0205513 (2018). Published 2018 Oct 9, doi: 10.1371/journal.pone.0205513.

[12] [12] M. Al-Sheikh, N. A. Iafe, N. Phasukkijwatana, S. R. Sadda and D. Sarraf, "Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography," Retina 38(2), 220–230 (2018), doi: 10.1097/IAE.000000000000 1628.

[13] [13] H. R. AttaALLah, A. A. M. Mohamed, M. A. Ali, "Macular vessels density in diabetic retinopathy: Quantitative assessment using optical coherence tomography angiography," Int. J. Ophthalmol. 39(8), 1845–1859 (2019), doi: 10.1007/s10792-018-1013-0.

[14] [14] P. M. Maloca, R. F. Spaide, E. R. de Carvalho et al., "Novel biomarker of sphericity and cylindricity indices in volume-rendering optical coherence tomography angiography in normal and diabetic eyes: A preliminary study," Graefes Arch. Clin. Exp. Ophthalmol. 258(4), 711–723 (2020), doi: 10.1007/s00417-019-04582-x.

[15] [15] H. A. Khan, M. A. Shahzad, F. Iqbal, M. A. Awan, M. Sharjeel, Q. A. Khan, F. Rashid, A. Abbas, A. A. Khan, M. U. Rehman, N. Khan, J. Pizzimenti, A. Mehmood, "A novel method of quantifying the Choriocapillaris in normal and post-inflammatory eyes," Ocul. Immunol. Inflamm. 18, 1–7 (2020), doi: 10.1080/09273948.2020.1800047. Epub ahead of print. PMID: 32809905.

[16] [16] L. B. Mostaco-Guidolin, M. S. D. Smith, M. Hewko et al., "Fractal dimension and directional analysis of elastic and collagen fiber arrangement in unsectioned arterial tissues affected by atherosclerosis and aging," J. Appl. Physiol. 126(3), 638–646 (2019), doi: 10.1152/japplphysiol.00497.2018.

[17] [17] R. Rocholz, M. M. Teussink, R. Dolz-Marco et al., SPECTRALIS Optical Coherence Tomography Angiography (OCTA): Principles and Clinical Applications Heidelberg Engineering Academy, Heidelberg, Germany (2018). Available at https://www.heidelbergengineering.com/media/e-learning/Totara/Dateien/pdf-tutorials/210111-001 SPEC TRALIS%20OCTA%20-%20Principles%20and%20Clinical%20Applications EN.pdf.

[18] [18] C. P. Wilkinson, F. L. Ferris, R. E. Klein et al., "Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales," Ophthalmology 110(9), 1677–1682 (2003), doi: 10.1016/S0161-6420(03)00475-5.

[19] [19] W. Gao, D. C. DeBuc, V. P. Zakharov et al., "Twodimensional fractal analysis of retinal tissue of healthy and diabetic eyes with optical coherence tomography," J. Biomed. Photonics Eng. 2, 040302 (2016).

[20] [20] K. W. Gossage, T. S. Tkaczyk, J. J. Rodriguez, J. K. Barton, "Texture analysis of optical coherence tomography images: Feasibility for tissue classification," J. Biomed. Opt. 8(3), 570–575 (2003), doi: 10.1117/1.1577575.

[21] [21] T. Santos, L. H. Warren, A. R. Santos, I. P. Marques, S. Kubach, L. G. Mendes, L. Sisternes, M. H. Madeira, M. Durbin, J. G. Cunha-Vaz. "Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR," Br. J. Ophthalmol. 22, 317890 (2020), doi: 10.1136/bjophthalmol-2020-317890. Epub ahead of print.PMID: 33355147.

[22] [22] Y. Kaizu, S. Nakao, M. Arima, T. Hayami, I. Wada, M. Yamaguchi, H. Sekiryu, K. Ishikawa, Y. Ikeda, K. H. Sonoda, "Flow density in optical coherence tomography angiography is useful for retinopathy diagnosis in diabetic patients," Sci. Rep. 9(1), 8668 (2019), doi: 10.1038/s41598-019-45194-z. PMID:31209251; PMCID: PMC6572797.

[23] [23] S. Bhardwaj, E. Tsui, S. Zahid, E. Young, N. Mehta, S. Agemy, P. Garcia, R. B. Rosen, J. A. Young, "Value of fractal analysis of optical coherence tomography angiography in various stages of diabetic retinopathy," Retina 38(9), 1816–1823 (2018), doi:10.1097/IAE.0000000000001774. PMID: 28723846.

[24] [24] M. Alam, D. Le, J. I. Lim, X. Yao, "Vascular complexity analysis in optical coherence tomography angiography of diabetic retinopathy," Retina (2020), doi: 10.1097/IAE.0000000000002874. Epub ahead of print. PMID: 32568980.

[25] [25] Y. S. Zhang, I. Mucollari, C. C. Kwan, G. Dingillo, J. Amar, G. W. Schwartz, A. A. Fawzi, "Reversed neurovascular coupling on optical coherence tomography angiography is the earliest detectable abnormality before clinical diabetic retinopathy," J. Clin. Med. 9(11), 3523 (2020), doi: 10.3390/jcm9113523.PMID: 33142724; PMCID: PMC7692675.

[26] [26] S. Zahid, R. Dolz-Marco, K. B. Freund, C. Balaratnasingam, K. Dansingani, F. Gilani, N. Mehta, E. Young, M. R. Klifto, B. Chae, L. A. Yannuzzi, J. A. Young, "Fractal dimensional analysis of optical coherence tomography angiography in eyes with diabetic retinopathy," Invest. Ophthalmol. Vis. Sci. 57(11), 4940–4947 (2016), doi: 10.1167/iovs.16-19656. PMID: 27654421.

[27] [27] W. Gao, "Improving the quantitative assessment of intraretinal features by determining both structural and optical properties of the retinal tissue with optical coherence tomography," University of Miami, Miami (2012).

[28] [28] A. M. Abu-El-Asrar, L. Dralands, L. Missotten, I. A. Al-Jadaan, K. Geboes, "Expression of apoptosis markers in the retinas of human subjects with diabetes," Invest. Ophthalmol. Vis. Sci. 45, 2760–2766 (2004), doi: 10.1167/iovs.03-1392.

[29] [29] A. J. Barber, D. A. Antonetti, T. S. Kern, C. E. N. Reiter, R. S. Soans, J. K. Krady et al., "The Ins2Akita mouse as a model of early retinal complications in diabetes," Invest. Ophthalmol. Vis. Sci. 46, 2210–2218 (2005), doi: 10.1167/iovs.04-1340.

[30] [30] A. Guha Mazumder, S. Chatterjee, S. Chatterjee, J. J. Gonzalez, S. Bag, S. Ghosh, A. Mukherjee, J. Chatterjee, "Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy," Clin. Ophthalmol. 11, 2073–2089 (2017), doi: 10.2147/ OPTH.S140110. PMID: 29200821; PMCID: PMC5703157.

[31] [31] H. A. Khan, F. Iqbal, M. A. Shahzad, Q. A. Khan, F. Rashid, M. Sharjeel, N. Khan, J. Pizzimenti, "Textural properties of Choriocapillaris on OCTA in healed inflammatory choriocapillaropathies. ophthalmic surg lasers imaging retina," 50(9), 566–572 (2019), doi: 10.3928/23258160-20190905-05. PMID: 31589754.

[32] [32] A. J. Nelson, Z. Chu, B. Burkemper, B. R. Chang, B. Xu, R. K. Wang, G. M. Richter, "Clinical utility of triplicate en face image averaging for optical coherence tomography angiography in glaucoma and glaucoma suspects," J. Glaucoma. 29(9), 823–830 (2020), doi: 10.1097/IJG.0000000000001570. PMID:32496464; PMCID: PMC7483809.

[33] [33] A. G. Elnahry, D. J. Ramsey, "Automated image alignment for comparing microvascular changes detected by fluorescein angiography and optical coherence tomography angiography in diabetic retinopathy," Semin. Ophthalmol. 2021 30, 1–8 (2020), doi: 10.1080/08820538.2021.1901122. Epubahead of print. PMID: 33784213.

[34] [34] S. G. Gadde, N. Anegondi, D. Bhanushali, L. Chidambara, N. K. Yadav, A. Khurana, A. Sinha Roy, "Quantification of vessel density in retinal optical coherence tomography angiography images using local fractal dimension," Invest. Ophthalmol. Vis. Sci. 57(1), 246–252 (2016), doi: 10.1167/iovs.15-18287. PMID: 26803800.